Alan M. Kirschenbaum

CMS Announces GENEROUS Model For Most Favored Nation Pricing In Medicaid

CMS Implements Major Drug Pricing Changes In CY 2026 Physician Fee Schedule Final Rule

First Few Details On MFN Pricing Emerge From HHS

Most Favored Nation Pricing Is Back – With A Vengeance

FDA Approves First State Drug Importation Program Under 20-Year-Old Statute, But High Hurdles Remain

CMS Finalizes Guidance On Medicare Part D Manufacturer Discount Program